Drug Database
IO

ior-egf/r3 (mur3)

✓ Approved

Center of Molecular Immunology · EGFR · 小分子

什么是 ior-egf/r3?

ior-egf/r3 是一种小分子,由Center of Molecular Immunology研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

商品名mur3
公司Center of Molecular Immunology
药物类别小分子, 影像药物
分子靶点EGFR
给药途径Injectable (Others)
状态Approved

作用机制

分子靶点

ior-egf/r3 作用于 1 个分子靶点:

EGFRepidermal growth factor receptor (ERBB1, NNCIS)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

ior-egf/r3 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Uterine cancer✓ Approved

相关研究文献

PubMedJournal of minimal access surgery2026-11-18

Resolution of plantar hyperhidrosis after thoracoscopic sympathectomy at R3 and R4: A retrospective study.

Al-Hurani Mohammad M, Al-Shamaileh Tamador T, Al-Zyoud Osama O, Hamouri Shadi S

Primary hyperhidrosis (HH) is a condition characterised by chronic, excessive sweating, with a global prevalence estimated to be between 2% and 4%. Endoscopic thoracic sympathectomy (ETS) is the recommended treatment for palmar hyperhidrosis (PAH), while lumbar sympathectomy is typically recommended for plantar hyperhidrosis (PLH). In this report, we investigate the improvement in PLH following ETS. We conducted a retrospective study for all patients who underwent bilateral ETS at King Abdullah University Hospital between 2010 and 2024. We looked for patients who had both PAH and PLH and underwent ETS at the third Rib (R3) and fourth rib (R4) levels. Data regarding demographics and surgery outcomes were collected. Ninety-six patients with palmoplantar hyperhidrosis (PPH) were identified. About 51 (53.1%) were males, and 45 (46.9%) were females. The mean age was 23 ± 7.34 years, and the mean body mass index (BMI) for all patients was 23.8 ± 4.1 kg/m 2 . In this cohort, the surgical procedure was successful in relieving PAH in 93 out of 96 patients (97%), whereas improvement in PLH was observed in only 16 out of 96 patients (16.7%), a difference that was statistically significant ( P < 0.001). Further analysis to assess the association between the success of PLH and different variables showed no association with age, BMI or gender. 26 out of 96 (27.1%) patients developed compensatory hyperhidrosis (CH) after the procedure; however, there was no significant association between the presence of CH or its severity with any patient-related factors such as age, gender or BMI. ETS at R3 and R4 is highly effective in treating PAH and has shown potential to improve PLH. However, the success rate of PPH has no significant association with any anthropometric and demographic factors that were included in this study.

PMID 43049302
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Topical Epidermal Growth Factor in Acne Vulgaris and Acne-Related Sequelae: Mechanistic Rationale, Clinical Evidence, and Formulation Challenges.

Gholizadeh Nasim N, Rahmatpour Rokni Ghasem G, Sahafi Maryam M, Mohaghegh Omid O et al.

Acne vulgaris (AV) is a common chronic inflammatory skin disorder, particularly among adolescents and young adults, and its management remains limited by variable treatment response, poor adherence, and treatment-related adverse effects. This review critically evaluates the mechanistic rationale, clinical evidence, safety considerations, and formulation challenges relating to topical epidermal growth factor (EGF) in active acne vulgaris and acne-related sequelae. PubMed was searched from database inception through June 30, 2026, using predefined MeSH and free-text terms related to AV, acne scarring, epidermal growth factor, EGF receptor (EGFR) signaling, keratinocytes, sebocytes, inflammation, skin-barrier repair, wound healing, and topical delivery. PubMed-indexed articles were selected through title-and-abstract screening followed by full-text assessment. Human acne-related studies were prioritized, while relevant preclinical studies were included to evaluate mechanistic, safety, and formulation-related evidence. Owing to substantial heterogeneity in study design and indication, evidence was synthesized narratively rather than quantitatively. Preclinical studies suggest that EGF/EGFR signaling may influence keratinocyte inflammation, migration, proliferation, and tissue repair; however, most of this evidence derives from non-acne cellular or wound-healing models. Direct clinical evidence for active acne is limited to two small, short-term split-face studies that reported preliminary within-study improvements in lesion-related outcomes. Separate small studies have evaluated topical EGF-containing formulations for established atrophic acne scars or recombinant human EGF (rhEGF) as an adjunct to fractional laser treatment. These studies do not demonstrate prevention of new acne scars, and evidence from scar or post-procedural settings cannot be extrapolated to active acne treatment. Heterogeneity in study design, formulation, indication, outcome assessment, and follow-up prevents firm conclusions regarding clinically meaningful efficacy, comparative effectiveness, or long-term safety. The single-database, English-language narrative-review methodology also limits the comprehensiveness and certainty of the synthesis. Available studies provide preliminary biological rationale and limited clinical signals for topical EGF in acne-related care, but the evidence is insufficient to establish clinically meaningful efficacy or an evidence-based therapeutic role in active acne vulgaris. Evidence for topical EGF serum used alone on established atrophic scars remains weak, whereas the comparatively broader evidence concerns rhEGF as an adjunct after fractional laser treatment for established scars. Even in this procedural setting, heterogeneous protocols and limited evidence certainty preclude routine recommendation. Topical EGF should therefore remain investigational, and larger randomized controlled trials using standardized formulations, active comparators, indication-specific outcomes, and longer safety follow-up are required.

PMID 43047248
阅读全文 →
PubMedPsychedelic medicine (New Rochelle, N.Y.)2026-11-18

A Practical Approach and Framework to Quality Management for Psychedelic Drug Development.

Lundin Dawn D

Sponsor companies and physician investigators engaged in clinical research, including those involved in psychedelic drug development, are to design quality into the clinical studies upfront as outlined in International Council for Harmonization (ICH) E8 R1, General Considerations for Clinical Studies, and ICH E6 R3, Guideline for Good Clinical Practice. Identification of what is critical to quality should be done at the time of protocol development, facilitating the assessment of risks to participants and data integrity. Sponsors should develop systems to manage quality throughout all stages of the trial process, per ICH E6, and ensure that quality oversight is commensurate with the risks associated in clinical development programs to support informed decision-making. Quality system elements should be designed to facilitate compliance, be flexible enough to accommodate shifting priorities, and mature with the growth of the company. For smaller start-up companies involved in psychedelic drug development programs, the same requirements apply as they would for the research and development of any other drug, biological, or device product. While there are challenges in developing a psychedelic for potential market approval due to controlled substance scheduling and the inclusion of psychological assistance or psychotherapy components, adherence to regulations is required to ensure participant safety and data reliability, which can be achieved through the establishment and maintenance of a robust quality management system.

PMID 43048013
阅读全文 →
PubMedThe Pediatric infectious disease journal2026-11-18

High Prevalence of Multidrug-resistant Gram-negative Bacteria on Neonatal Intensive Care Unit Surfaces at a Tertiary Hospital in Kampala, Uganda.

Wamawobe Amusa A, Hookham Lauren L, Nabirye Loy L, Namazzi Maimuna M et al.

About 60% of neonatal sepsis cases are hospital-acquired and are often caused by Gram-negative bacteria, with a high rate of antimicrobial resistance. Outbreaks of multidrug-resistant bacteria in neonatal units occur at rates 20 times higher in low- and middle-income countries than in high-income settings. We conducted 4 rounds (R1-4) of environmental sampling in a neonatal intensive care unit (NICU) in Kampala, Uganda, to inform an infection prevention and control (IPC) program tailored to a resource-limited setting. Eighty-two swabs were taken over 12 months (2021-2022) from n = 13 high-touch surfaces, n = 10 low-touch surfaces (R1-3) and n = 6 staff items (R4). Potential pathogens were identified using standard biochemical methods. Antimicrobial susceptibility testing was performed using Kirby-Bauer disk diffusion. Hand hygiene audits were conducted throughout the study period. A collaborative working group of NICU, IPC and research staff co-developed IPC interventions. Of 146 organisms isolated, 127 (82%) were potential pathogens, predominantly Pseudomonas spp., Acinetobacter spp. and Citrobacter spp. High-touch sites such as sinks, cots and drug trolleys showed persistent contamination. Resistance to first-line antibiotics was high: gentamicin (48/91, 52%), ampicillin (25/25, 100%) and ceftazidime (30/91, 33%). After color-coded feedback, a unit-wide deep clean reduced potential pathogens by 60% from R1 (n = 63) to R2 (n = 25). However, levels rebounded in R3 (n = 32), representing a 21% increase compared with R2 (n = 25), highlighting inconsistencies in cleaning. Targeted environmental cleaning can reduce NICU contamination by multidrug-resistant Gram-negative bacterial pathogens. Sinks were persistent reservoirs, underscoring the need for consistent daily cleaning and staff engagement. In low- and middle-income country settings, simple, low-cost IPC measures informed by environmental surveillance may support sustainable hospital-acquired infection reduction.

PMID 43046301
阅读全文 →
PubMedFrontiers in pediatrics2026-11-18

Quantitation and clinical implications of lactadherin in human breast milk.

Li Yue Y, Xu Jian J, Chen Tong-Xin TX, Wu Jing J

Lactadherin (also known as milk fat globule-EGF factor 8, MFG-E8) is a major bioactive component of the milk fat globule membrane (MFGM) in human milk and plays important roles in immune regulation, intestinal homeostasis, and host defense. However, data regarding lactadherin concentrations in human milk and the maternal factors influencing its levels remain limited. This study aimed to characterize lactadherin concentrations across different lactation stages, identify potential determinants of lactadherin variation, and explore its associations with infant health outcomes. A total of 91 Chinese mother-infant pairs were enrolled in this prospective cohort study. Maternal and infant demographic characteristics and clinical information were collected through medical records and structured questionnaires. Colostrum and mature milk samples were collected, and lactadherin concentrations were quantified using a modified enzyme-linked immunosorbent assay (ELISA). Infants were followed up to 6 months after birth through telephone interviews to record feeding patterns and the occurrence of common infantile diseases. Lactadherin concentrations were significantly higher in colostrum than in mature milk (median: 112.79 μg/mL vs. 10.51 μg/mL, respectively; P < 0.0001), indicating a substantial decline in lactadherin levels during lactation. Maternal allergy history was identified as an independent factor associated with lactadherin concentrations. Specifically, maternal allergy history was associated with lower lactadherin concentrations in colostrum (β= -53.16, P = 0.039) but higher concentrations in mature milk (β = 7.38, P = 0.024). Furthermore, a significant interaction between maternal allergy history and lactation stage was observed (P = 0.0007), suggesting a stage-dependent association between maternal allergy history and lactadherin levels. No significant associations were observed between lactadherin concentrations in human milk and the incidence of infantile diseases during the follow-up period. Lactadherin concentration in human milk varies substantially across lactation stages and is influenced by maternal allergy history. Further studies are needed to elucidate the underlying mechanisms governing lactadherin dynamics and to determine their implications for infant health and nutritional applications.

PMID 43047433
阅读全文 →
PubMedBMC oral health2026-11-17

Does operator experience affect root canal shaping quality with single-file NiTi Systems?

Isik Vasfiye V, Kayahan Mehmet Baybora MB, AbuTahun Ibrahim H IH, Kwak Sang Won SW et al.

This study aimed to evaluate the influence of the operator's experience on shaping ability with single-file Nickel-Titanium systems. The One Curve (OC) rotary file system and the One RECI (OR) reciprocating file system, both with a tip size of #25/0.06, were used by four inexperienced clinicians (IOC and IOR) and four endodontists (EOC and EOR) to shape endo-training blocks with J-shaped simulated canals. Each operator prepared 5 canals per system, giving 20 canals per group. Pre- and post-operative images of simulated canals were superimposed. The total amount of straightening and the change in the radius of curvature and centering ratios were determined. The results were analyzed using two-way analysis of variance, with operator experience and file system as fixed factors, followed by Tukey's post hoc comparison at a significance level of 95%. The One RECI system produced significantly greater overall straightening than the One Curve system (p = 0.016), while operator experience had no significant effect on straightening or on the change in the radius of curvature (p > 0.05). Operators experience significantly affected the centering ratio from the apical third to the center of the curvature (p < 0.05), with inexperienced operators generally achieving higher centering ratios, except near the center of curvature. No effect of experience was found at the apical terminus or in the coronal, straight portion of the canal (p > 0.05). Inexperienced operators using the One RECI system achieved significantly higher centering ratios than all other groups in the apical third (p < 0.05). No significant experience × system interaction was found for any parameter. Within the limitations of the present study, shaping outcomes with single-file NiTi systems were influenced by both operator experience and instrument kinematics, although no significant interaction between these factors was detected.

PMID 43040314
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多ior-egf/r3